Senti BiosciencesSNTI
13F holders, Q3 2024 (September 30)2holders −18
0new positions
17sold out
$2.26avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, down 18 from Q2 2024. 0 opened new positions and 17 sold out. The largest holders were 8VC GP I, LLC ($573K) and Intel Corp ($109K).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 17 | $2.0M |
All 13F filers, Q2 2024 → Q3 2024: 10,032,620 shares sold, net −10,032,620 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| 8VC GP I, LLC | 0.78% | Reduce -90.0% | 253,755 | $573K |
| Intel Corp | 0.04% | Reduce -91.9% | 48,048 | $109K |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.